A "new-old" way of thinking about brain disorder, cerebral excitability - The fundamental property of nervous tissue

Medical Hypotheses

Volumn 64, Issue 1, 2005, Pages 142-150

  Saugstad, Letten F ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CONVULSANT AGENT; NEUROLEPTIC AGENT;

AGE DISTRIBUTION; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; CIRCADIAN RHYTHM; DEPRESSION; ELECTROENCEPHALOGRAM; EPILEPSY; HEMIANOPIA; HUMAN; MANIA; MIGRAINE; NERVOUS TISSUE; NEUROPROTECTION; PARKINSONISM; PHOTOPHOBIA; PRIORITY JOURNAL; PSYCHOSIS; PUBERTY; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SCOTOMA; SYNAPSE; VISUAL DISORDER; VISUAL SYSTEM;

EID: 7944223222     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.05.006     Document Type: Article

References (61)

1. Ajmone Marsan C., Zivin L.S. Factors related to the occurrence of typical paroxysmal abnormalities in the EEG. Epilepsia. 11:1970;361-369
2. Astrup C. Impression from a study tour to USSR. Nordic Psychiatr. J. 1:1951;1-7
3. Boyce P., Parker G. Seasonal affective disorder in the southern hemisphere. Am. J. Psychiatr. 145:1988;96-99
4. Brain Lord Diseases of the nervous system. 1962;Oxford University Press
5. Bray P.F., Wiser W.C. Evidence for a genetic etiology of temporal central abnormalities in focal epilepsy. New Engl. J. Med. 171:1964;926-934
6. Clementz B.A., Keil A., Kissler J. Aberrant brain dynamics in schizophrenia: delayed buildup and prolonged decay of the visual steady-state response. Cogn. Brain Res. 18:2004;121-129
7. Cohen W.J., Cohen N.H. Lithium carbonate, haloperidol and irreversible brain damage. JAMA. 230:1974;1283-1287
8. Crawford M. Cerebral evolution. Nutr. Health. 16:2002;29-34
9. Dawson EG. The relationship of tap water and physiological level of Lithium, mental hospital admission and homicide in Texas. In: Schrauzer GN, Klippel K-F, editors. Lithium in biology and medicine. Weinheim VCH; 1991. p. 169-187 [incl. Ref. To 1970 and 1972]
10. Deutsch A.Y. Prefrontal dopamine system. Implication for Parkinson's disease and schizophrenia. J. Neural. Transmis. Gener. 91:1993;197-221
11. Dow D.J., Witty C.W.M. Electroencephalographic changes in migraine. Lancet. ii:1947;52-56
12. Engels G.L., Ferris E.H. Jr., Romano J. Focal electroencephalographic changes in migraine. Am. J. Med. Sci. 209:1945;650-654
13. Esiri M et al. Olfactory bulb in Parkinsonian disease; 1984
14. Fletcher N. Donagh M. Brain: textbook of the nervous system. 11th ed.:2001;Oxford University Press
15. Hoffman R.E., Dobscha S.K. Cortical pruning and the development of schizophrenia: a computer model. Schiz. Bull. 15:1989;477-490
16. Howland R.H. Bipolar disorder associated with primary generalised epilepsy. Brit. J. Psychiatr. 173:1993;330-333
17. Ikemoto A., Atasumi N., Fufukawa S., et al. Dietary N-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci. Lett. 285:2000;998-1002
18. Jin Y., Potkin S.G., Rice D., Sramek J., Costa J., Isenhart R., et al. Abnormal EEG responses to photic stimulation in schizophrenic patients. Schizophr. Bull. 16(4):1990;627-634
19. Jin Y., Potkin S.G., Sandman C.A., Bunney W.E. Jr. Topographic analysis of EEG photic driving in patients with schizophrenia following clozapine treatment. Clin. Electroencephalogr. 29(2):1998;73-78
20. Kiloh L.G., McComas A.J., Osselton J.W. Clinical electroencephalography. 1972;Butterworths, London
21. Kilzieh N., Akiskal H.S. Rapid cycling bipolar disorder. An overview research and clinical experience. Psychiat. Clin. North Am. 22:1998;585-607
22. Kopala L.C., Clark C., Hurwitz T. Olfactory deficits in neuroleptic native patients with schizophrenia. Schiz. Res. 8:1992;245-250
23. Kretschmer E. Körperbau und character. 1921;Springer, Heidelberg. p. 321
24. Leaf A., Kang J.X., Xiao Y.-F., et al. Functional and electrophysiological effects of polyunsaturated fatty acids on excitable tissues: heart and brain. Prostagland. Leucotr. Essent. Fatty Acids. 50:1999;307-312
25. Lennox W.G., Lennox M.A. Epilepsy and related disorders. vol. I:1960;J. & A. Churchill Ltd, London
26. Levy A.B., Drake M.E., Shy K.E. EEG evidence of epileptiform paroxysm in rapid cycling bipolar patients. J. Clin. Psychiatr. 49:1988;232-234
27. Liu N., Grumbach M.M., de Napoli R.A., Morishima A. Prevalence of electroencephalographic abnormalities in idiopathic precocious puberty. J. Clin. Endocrinol. 25:1965;1296-1308
28. McCulloch W.S. The reliability of biological systems. Self organizing systems. 1960;Pergamon Press, London
29. Menes C.P., Hoaken P.C. Untoward effect following combined neuroleptics-lithium treatment. Cardiac arrhytmias and seizure. Can. J. Psychiatr. 25:1980;573-576
30. Merritt H.H. A textbook of neurology. 1955;Henry Kimpton, Publ., London
31. Metrakos K., Metrakos J.D. Genetics of convulsive disorder. II Genetics and electroencephalographic studies of centrencephalic epilepsy. Neurology. 11:1961;474-480
32. Molteni R., Barnard J., Yino Z., et al. A highfat refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity and learning. Neuroscience. 112:2002;803-814
33. Moore G.J., Bebchuk J.M., Khondakar H., et al. Lithium increases N-acetyl aspartate in the human brain. In vivo evidence in support of bcl-2s neurotrophic effects? Biol. Psychiat. 48:2000;1-8
34. Naquet R., Fegersten Saugstad L., Bert J. Seizure discharges localised to the posterior cerebral regions in man. EEG Clin. Neurophysiol. 13:1960;305-316
35. Nonaka D., Chuang D.M. Neuroprotective effects of chronic lithium of focal cerebral ischemia in rats. Neuroreport. 9:1998;2081-2084
36. Pavlov I.P. Conditioned reflexes. 1927;Oxford University Press, London
37. Petersen I.P., Eeg-Olofson O., Sellden U. Paroxysmal activity in EEG of normal children. Kellaway P., Petersen I. Clinical electroencephalography in children. 1968;167-196 Grune & Stratton, New York
38. Pincus J.H., Tucker G.J. Behavioural neurology. 1985;Oxford University Press
39. Rapoport S.J. Integrated phylogeny of the primate brain with special reference to human and their disease. Brain Res. Rev. 15:1990;267-290
40. Reading P.J. Frontal lobe dysfunction in schizophrenia and in Parkinson's disease. J. R. Soc. Med. 84:1991;340-353
41. Roxanas A.C., Carbott A.J., Reid W.G.A. A patient with mania and photo-convulsive epilepsy. Aust. NZ. J. Psychiatr. 30:1996;867-879
42. Russel G.F.M. Anorexia nervosa and bulimia nervosa. Russel G.F.M, Hersov L.A. Handbook of psychiatry. vol. 4:1983;285-297 Cambridge University Press
43. Salvesen R., Bekkelund S.I. Migraine as compared to other headaches, is worse during Midnight Sun summer than during Polar night. Headache. 40:2000;824-829
44. Saugstad L.F. EEG in brain-damaged children with and without mental retardation. Gruenwald K., Wessman L., Alsén B.N. 13th Nordic congress on mental retardation. 1967;344-348 Berlingske Bogtrykkeri, Copenhagen
45. Saugstad L.F. Social class, marriage, and fertility in schizophrenia. Schizophr. Bull. 15(1):1989;9-43
46. Saugstad L.F. The maturational theory of brain development and cerebral excitability in the multifactorially inherited manic-depressive psychosis and schizophrenia. Int J Psychophysiol. 18(3):1994;189-203. [December, Special issue: Developmental Psychophysiology]
47. Saugstad L.F. Deviation in cerebral excitability. Possible clinical implications. Int J Psychophysiol. 18(3):1994;205-212. [December, Special issue: Developmental Psychophysiology]
48. Saugstad L.F. A lack of cerebral lateralisation in schizophrenia is within the normal variation in brain maturation but indicates late, slow maturation. Schizophr. Res. 39(3):1999;183-196
49. Saugstad L.F. Suicide and resilience. The role of mental illness, psychotropic medication and abuse. Editorial Int. Med. J. 7(3):2000;169-179
50. Saugstad L.F. Manic-depressive psychosis and schizophrenia are neurological disorders at the extremes of CNS maturation and nutritional disorders associated with a deficit in marine fat. Med. Hypotheses. 57:2001;679-692
51. Saugstad L.F. Changing panorama of mental illness, the role of environment - a key to prevention? J. Norw. Epidemiol. 12:2002;291-300
52. Saugstad L.F. Our neglect of the normal variation is linked to a reluctance to accept multifactorial inheritance and the role of environment. Med. Hypothesis. 60(2):2003;181-187
53. Saugstad L.F. From superior adaptation and function to brain dysfunction - the neglect of epigenetic factors. Nutr. Health. 2004
54. Saugstad L.F., Ødegaard Ø. Recent rise in supposedly stress-dependent causes of death in psychiatric hospitals. Acta Psychiatr. Scand. 71:1985;402-409
55. Schrautzer N., Shrestha K.P. Lithium in the drinking water and the incidence of crimes, suicides and arrests related to drug addictions. Schrautzer N., Klippel K.-F. Lithium in biology and medicine. 1991;190-203 Weinheim Publ. VCH
56. Shelley A.-M., Silipo G., Javitt D.C. Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction. Schizophr. Res. 37:1999;65-79
57. Sherrington Sir Charles. On man and his nature; 1952
58. Wehr T.A., Goodwin F.K. Can anti-depressants cause mania and worsen the course of affective illness? Am. J. Psychiatr. 144:1987;140-151
59. Wu A., Molteni R., Ying W., et al. A saturated fat diet aggravates the outcome of traumatic brain injury and hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor. Neuroscience. 119:2003;365-375
60. Zhi-Jun Zhang, Zhi-Jian Iao, Wen Liu, Qun Fang, Gavin P.R. Effects of anti-psychotics on fat deposition. Brit. J. Psychiatr. 184:2004;58-62
61. Ødegaard Ø. The incidence of mental disease in Norway during World War II. Acta Psychiatr. Neurol. Scand. 29:1954;333-353